Extensions of Remarks E1463 EXTENSIONS of REMARKS
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
GAO-09-878R Project Bioshield Act: HHS Has Supported Development
United States Government Accountability Office Washington, DC 20548 July 24, 2009 Congressional Committees Subject: Project BioShield Act: HHS Has Supported Development, Procurement, and Emergency Use of Medical Countermeasures to Address Health Threats This report formally transmits the attached briefing in response to section 247d-6c of title 42 of the United States Code. (See the enclosure.) The statute required the Comptroller General to examine the Department of Health and Human Services’ (HHS) support for the development and procurement of and authority for the emergency use of medical countermeasures to address chemical, biological, radiological, and nuclear threats to public health, and provide the results to the congressional committees by July 21, 2009.1 HHS determines priorities for medical countermeasure procurement based on those chemical, biological, radiological, and nuclear agents that have been identified by the Department of Homeland Security as posing a material threat to the U.S. population that could affect national security. We provided the briefing to staff of your committees to satisfy the mandate reporting requirement on July 20, 2009, and July 21, 2009. – – – – – We are sending copies of this report to the Secretary of HHS, the Secretary of Homeland Security, and other interested parties. In addition, the report will be available at no charge on the GAO Web site at http://www.gao.gov. If you or your staff have any questions regarding this report, please contact me at (202) 512- 7114 or [email protected]. Contact points for our Offices of Congressional Relations and Public Affairs may be found on the last page of this report. -
A Circular History of Modern Chamorro Activism
Claremont Colleges Scholarship @ Claremont Pomona Senior Theses Pomona Student Scholarship 2021 The Past as "Ahead": A Circular History of Modern Chamorro Activism Gabby Lupola Follow this and additional works at: https://scholarship.claremont.edu/pomona_theses Part of the Asian American Studies Commons, Ethnic Studies Commons, Indigenous Studies Commons, Micronesian Studies Commons, Military History Commons, Oral History Commons, Political History Commons, Social History Commons, and the United States History Commons Recommended Citation Lupola, Gabby, "The Past as "Ahead": A Circular History of Modern Chamorro Activism" (2021). Pomona Senior Theses. 246. https://scholarship.claremont.edu/pomona_theses/246 This Open Access Senior Thesis is brought to you for free and open access by the Pomona Student Scholarship at Scholarship @ Claremont. It has been accepted for inclusion in Pomona Senior Theses by an authorized administrator of Scholarship @ Claremont. For more information, please contact [email protected]. The Past as “Ahead”: A Circular History of Modern Chamorro Activism Gabrielle Lynn Lupola A thesis submitted in partial fulfillment of the requirements for the degree of Bachelor of Arts in History at Pomona College. 23 April 2021 1 Table of Contents Images ………………………………………………………………….…………………2 Acknowledgments ……………………..……………………………………….…………3 Land Acknowledgment……………………………………….…………………………...5 Introduction: Conceptualizations of the Past …………………………….……………….7 Chapter 1: Embodied Sociopolitical Sovereignty on Pre-War Guam ……..……………22 -
Download This Volume
Photograph by Carim Yanoria Nåna by Kisha Borja-Quichocho Like the tåsa and haligi of the ancient Chamoru latte stone so, too, does your body maintain the shape of the healthy Chamoru woman. With those full-figured hips features delivered through natural birth for generations and with those powerful arms reaching for the past calling on our mañaina you have remained strong throughout the years continuously inspire me to live my culture allow me to grow into a young Chamoru woman myself. Through you I have witnessed the persistence and endurance of my ancestors who never failed in constructing a latte. I gima` taotao mo`na the house of the ancient people. Hågu i acho` latte-ku. You are my latte stone. The latte stone (acho` latte) was once the foundation of Chamoru homes in the Mariana Islands. It was carved out of limestone or basalt and varied in size, measuring between three and sixteen feet in height. It contained two parts, the tasa (a cup-like shape, the top portion of the latte) and the haligi (the bottom pillar) and were organized into two rows, with three to seven latte stones per row. Today, several latte stones still stand, and there are also many remnants of them throughout the Marianas. Though Chamorus no longer use latte stones as the foundations of their homes, the latte symbolize the strength of the Chamorus and their culture as well as their resiliency in times of change. Micronesian Educator Editor: Unaisi Nabobo-Baba Special Edition Guest Editors: Michael Lujan Bevacqua Victoria Lola Leon Guerrero Editorial Board: Donald Rubinstein Christopher Schreiner Editorial Assistants: Matthew Raymundo Carim Yanoria Design and Layout: Pascual Olivares ISSN 1061-088x Published by: The School of Education, University of Guam UOG Station, Mangilao, Guam 96923 Contents Guest Editor’s Introduction ............................................................................................................... -
CONGRESSIONAL RECORD— Extensions of Remarks E1470 HON
E1470 CONGRESSIONAL RECORD — Extensions of Remarks July 14, 2003 ANGEL ANTHONY LEON GUERRERO Guerrero Santos, III. Adios Angel. Si Yu’us erick (Fred) W. Rosen. Mr. Rosen was a SANTOS Ma’ase. Naval Officer, a businessman, a hometown f hero, and above all, a patriot. He was a friend to a President and national leaders and a wit- HON. MADELEINE Z. BORDALLO PERSONAL EXPLANATION OF GUAM ness to history. For his contributions to Dalton, Georgia and indeed the history of this great IN THE HOUSE OF REPRESENTATIVES HON. LORETTA SANCHEZ nation, I pay honor to him posthumously; Mr. Monday, July 14, 2003 OF CALIFORNIA Rosen died peacefully on July 14, 2003. Ms. BORDALLO. Mr. Speaker, I rise today IN THE HOUSE OF REPRESENTATIVES Fred Rosen was born in 1917 in Brooklyn, New York, the son of Eastern European Jew- to pay tribute to former Guam Senator Angel Monday, July 14, 2003 Anthony Leon Guerrero Santos, III, a tireless ish immigrants. In the 1930s, as the Depres- champion of the rights of the Chamorro peo- Ms. LORETTA SANCHEZ of California. Mr. sion consumed the nation, Mr. Rosen’s broth- ple. Sadly, Angel passed away on July 6, Speaker, on Thursday, July 10, I was unavoid- er Ira moved to Dalton, Georgia seeking op- 2003 after suffering from a degenerative ill- ably detained due to a prior obligation in my portunity in the textile industry by opening the ness. district. La Rose Bedspread Company. Mr. Rosen was Angel was born on April 14, 1959 to Aman- I request that the CONGRESSIONAL RECORD a loyal Bulldog, attending the University of da Leon Guerrero Santos and Angel Cruz reflect that had I been present and voting, I Georgia and playing football there. -
Project Bioshield Act of 2004
PUBLIC LAW 108–276—JULY 21, 2004 118 STAT. 835 Public Law 108–276 108th Congress An Act To amend the Public Health Service Act to provide protections and countermeasures against chemical, radiological, or nuclear agents that may be used in a terrorist attack against the United States by giving the National Institutes of Health July 21, 2004 contracting flexibility, infrastructure improvements, and expediting the scientific [S. 15] peer review process, and streamlining the Food and Drug Administration approval process of countermeasures. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, Project BioShield Act of 2004. SECTION 1. SHORT TITLE. 42 USC 201 note. This Act may be cited as the ‘‘Project BioShield Act of 2004’’. SEC. 2. BIOMEDICAL COUNTERMEASURE RESEARCH AND DEVELOP- MENT—AUTHORITIES. (a) IN GENERAL.—Part B of title III of the Public Health Service Act (42 U.S.C. 243 et seq.) is amended by inserting after section 319F the following section: ‘‘SEC. 319F–1. AUTHORITY FOR USE OF CERTAIN PROCEDURES 42 USC 247d–6a. REGARDING QUALIFIED COUNTERMEASURE RESEARCH AND DEVELOPMENT ACTIVITIES. ‘‘(a) IN GENERAL.— ‘‘(1) AUTHORITY.—In conducting and supporting research and development activities regarding countermeasures under section 319F(h), the Secretary may conduct and support such activities in accordance with this section and, in consultation with the Director of the National Institutes of Health, as part of the program under section 446, if the activities concern qualified countermeasures. ‘‘(2) QUALIFIED COUNTERMEASURE.—For purposes of this section, the term ‘qualified countermeasure’ means a drug (as that term is defined by section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. -
Biosecurity: a Comprehensive Action Plan Center for American Progress
Center for American Progress Biosecurity A Comprehensive Action Plan Andrew J. Grotto Jonathan B. Tucker Progressive Ideas for a Strong, Just, and Free America Biosecurity: A Comprehensive Action Plan Center for American Progress Biosecurity A Comprehensive Action Plan Andrew J. Grotto and Jonathan B. Tucker June 2006 After Guantanamo: A Special Tribunal for International Terrorist Suspects 1 Biosecurity: A Comprehensive Action Plan Center for American Progress Table of Contents EXECUTIVE SUMMARY i BIOLOGICAL THREATS FACING THE UNITED STATES 1 PREVENTING BIO-CATASTROPHES: THE NEED FOR A GLOBAL APPROACH 9 PREVENTING THE MISUSE OF THE LIFE SCIENCES 9 RECOMMENDATIONS STRENGTHENING BIOLOGICAL DISARMAMENT MEASURES 14 RECOMMENDATIONS 8 CONTAINING DISEASE OUTBREAKS: AN INTEGRATED PUBLIC HEALTH STRATEGY 21 TIMELY DETECTION OF OUTBREAKS 22 RECOMMENDATIONS 0 RAPID CONTAINMENT OF OUTBREAKS 32 RECOMMENDATIONS 5 DEFENDING AGAINST BIOLOGICAL THREATS: AN INTEGRATED RESEARCH STRATEGY 37 REFORMING THE DRUG DEVELOPMENT PROCESS 38 RECOMMENDATIONS 41 RATIONALIZING BIODEFENSE SPENDING 42 RECOMMENDATIONS 44 GLOSSARY 47 Biosecurity: A Comprehensive Action Plan ACKNOWLEDGMENTS The authors are deeply grateful to the following individuals for their valuable comments and criticisms on earlier drafts of this report: Bob Boorstin, Joseph Cirincione, P. J. Crowley, Richard Ebright, Gerald L. Epstein, Trevor Findlay, Brian Finlay, Elisa D. Harris, David Heyman, Ajey Lele, Dan Matro, Caitriona McLeish, Jonathan Moreno, Peter Ogden, Alan Pearson, Michael Schiffer, Laura Segal, and Bradley Smith. 4 Center for American Progress Executive Summary iological weapons and infectious diseases share several fundamental characteristics that the United States can leverage to counter both Bof these threats more effectively. Both a bioweapons attack and a natural pandemic, such as avian flu, can be detected in similar ways, and the effectiveness of any response to an outbreak of infectious disease, whether natural or caused deliberately by terrorists, hinges on the strength of the U.S. -
The Project Bioshield Act: Issues for the 112Th Congress
The Project BioShield Act: Issues for the 112th Congress Frank Gottron Specialist in Science and Technology Policy March 13, 2012 Congressional Research Service 7-5700 www.crs.gov R42349 CRS Report for Congress Prepared for Members and Committees of Congress The Project BioShield Act: Issues for the 112th Congress Summary In 2004, Congress passed the Project BioShield Act (P.L. 108-276) to provide the federal government with new authorities related to the development, procurement, and use of medical countermeasures against chemical, biological, radiological, and nuclear (CBRN) terrorism agents. As the expiration of some of these authorities approaches, Congress is considering whether these authorities have sufficiently contributed to national preparedness to merit extension. The Project BioShield Act provides three main authorities: (1) guaranteeing a federal market for new CBRN medical countermeasures, (2) permitting emergency use of countermeasures that are either unapproved or have not been approved for the intended emergency use, and (3) relaxing regulatory requirements for some CBRN terrorism-related spending. The Department of Health and Human Services (HHS) has used each of these authorities. The HHS obligated approximately $2.5 billion to guarantee a government market for countermeasures against anthrax, botulism, radiation, and smallpox. The HHS allowed the emergency use of several unapproved products, including during the 2009 H1N1 influenza pandemic. The HHS used expedited review authorities to approve contracts and grants related to CBRN countermeasure research and development. The Department of Homeland Security (DHS) Appropriations Act, 2004 (P.L. 108-90) advance- appropriated $5.593 billion to acquire CBRN countermeasures through Project BioShield for FY2004-FY2013. Through FY2012, subsequent Congresses have removed $1.876 billion from this account through rescissions and transfers, more than one-third of the advance appropriation. -
Project Bioshield Act Fact Sheet
ASTHO LEGAL PREPAREDNESS SERIES EMERGENCY USE AUTHORIZATION TOOLKIT Project BioShield Act Fact Sheet Overview With the anthrax and other terrorist attacks of 2001, the federal government determined that it would need new medical countermeasures, such as diagnostic tests, drugs, and vaccines, to respond to an attack using chemical, biological, radiological, or nuclear (CBRN) agents.1 The lack of a significant commercial market for CBRN countermeasures was identified as a reason for the dearth of such countermeasures.1 Since diseases and conditions caused by CBRN agents occur infrequently, the private sector did not have an economic incentive to invest the millions of dollars necessary to research and develop such measures.1 The Project BioShield Act of 20042 was enacted to accelerate the research, development, purchase, and availability of effective medical products against CBRN agents.3 Project BioShield provided the government with the authority and funding to develop, acquire, stockpile, and distribute the medical products needed to protect the United States against weapons of mass destruction.3 Note: As of March 2012, Congress is in the process of reauthorizing the Pandemic and All-Hazards Preparedness Act (PAHPA), which may impact some provisions of the Project BioShield Act. Please see ASTHO EUA Current Issues Winter 2012 for more information about reauthorization and its potential impact on EUAs and related issues. What the Law Does The Project BioShield Act authorizes expedited procurement, streamlined personnel appointments, expedited peer review, biomedical countermeasures procurement, emergency use of medical countermeasures, and other biodefense activities. Liability Protections The Project BioShield Act does not contain any explicit immunity or other liability protections. -
Failures of Project Bioshield & Congressional Attempts to Remedy It
DePaul Journal of Health Care Law Volume 10 Issue 3 Spring 2007 Article 8 October 2015 Failures of Project BioShield & Congressional Attempts to Remedy It Megan O'Reilly Follow this and additional works at: https://via.library.depaul.edu/jhcl Recommended Citation Megan O'Reilly, Failures of Project BioShield & Congressional Attempts to Remedy It, 10 DePaul J. Health Care L. 503 (2007) Available at: https://via.library.depaul.edu/jhcl/vol10/iss3/8 This Case Briefs is brought to you for free and open access by the College of Law at Via Sapientiae. It has been accepted for inclusion in DePaul Journal of Health Care Law by an authorized editor of Via Sapientiae. For more information, please contact [email protected]. CASE BRIEF: THE FAILURES OF PROJECT BIOSHIELD & CONGRESSIONAL ATTEMPTS TO REMEDY IT Megan O'Reilly I. THE THREAT OF A BIOLOGICAL TERROR ATTACK In response to the 2001 terrorist attacks, the United States government began a crash program to develop drugs, vaccine and diagnostic tests to protect the nation from biological terrorism.' As part of this effort, President Bush signed Project BioShield into law on July 21, 2004. The legislation was intended to facilitate a faster process to research, develop, purchase and make bioterrorism countermeasures available to combat bioterrorist threats. 2 However, Project BioShield is not drawing the interest it aimed for. The legislation has faced significant criticism because the law has failed to adequately provide consistent and well-coordinated financing, and sufficient, ensured markets, as well as any liability protection for vaccine developers. 3 The threat of a biological attack is very real.4 To ensure that Project BioShield assists in protecting the nation from future bioterrorist attacks, it is necessary to evaluate the successes and setbacks the initiative has faced. -
AAPI National Historic Landmarks Theme Study Essay 12
National Park Service U.S. Department of the Interior A National Historic Landmarks Theme Study ASIAN AMERICAN PACIFIC ISLANDER ISLANDER AMERICAN PACIFIC ASIAN Finding a Path Forward ASIAN AMERICAN PACIFIC ISLANDER NATIONAL HISTORIC LANDMARKS THEME STUDY LANDMARKS HISTORIC NATIONAL NATIONAL HISTORIC LANDMARKS THEME STUDY Edited by Franklin Odo Use of ISBN This is the official U.S. Government edition of this publication and is herein identified to certify its authenticity. Use of 978-0-692-92584-3 is for the U.S. Government Publishing Office editions only. The Superintendent of Documents of the U.S. Government Publishing Office requests that any reprinted edition clearly be labeled a copy of the authentic work with a new ISBN. Library of Congress Cataloging-in-Publication Data Names: Odo, Franklin, editor. | National Historic Landmarks Program (U.S.), issuing body. | United States. National Park Service. Title: Finding a Path Forward, Asian American and Pacific Islander National Historic Landmarks theme study / edited by Franklin Odo. Other titles: Asian American and Pacific Islander National Historic Landmarks theme study | National historic landmark theme study. Description: Washington, D.C. : National Historic Landmarks Program, National Park Service, U.S. Department of the Interior, 2017. | Series: A National Historic Landmarks theme study | Includes bibliographical references and index. Identifiers: LCCN 2017045212| ISBN 9780692925843 | ISBN 0692925848 Subjects: LCSH: National Historic Landmarks Program (U.S.) | Asian Americans--History. | Pacific Islander Americans--History. | United States--History. Classification: LCC E184.A75 F46 2017 | DDC 973/.0495--dc23 | SUDOC I 29.117:AS 4 LC record available at https://lccn.loc.gov/2017045212 For sale by the Superintendent of Documents, U.S. -
Public Law 108–276 108Th Congress An
PUBLIC LAW 108–276—JULY 21, 2004 118 STAT. 835 Public Law 108–276 108th Congress An Act To amend the Public Health Service Act to provide protections and countermeasures against chemical, radiological, or nuclear agents that may be used in a terrorist attack against the United States by giving the National Institutes of Health July 21, 2004 contracting flexibility, infrastructure improvements, and expediting the scientific [S. 15] peer review process, and streamlining the Food and Drug Administration approval process of countermeasures. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, Project BioShield Act of 2004. SECTION 1. SHORT TITLE. 42 USC 201 note. This Act may be cited as the ‘‘Project BioShield Act of 2004’’. SEC. 2. BIOMEDICAL COUNTERMEASURE RESEARCH AND DEVELOP- MENT—AUTHORITIES. (a) IN GENERAL.—Part B of title III of the Public Health Service Act (42 U.S.C. 243 et seq.) is amended by inserting after section 319F the following section: ‘‘SEC. 319F–1. AUTHORITY FOR USE OF CERTAIN PROCEDURES 42 USC 247d–6a. REGARDING QUALIFIED COUNTERMEASURE RESEARCH AND DEVELOPMENT ACTIVITIES. ‘‘(a) IN GENERAL.— ‘‘(1) AUTHORITY.—In conducting and supporting research and development activities regarding countermeasures under section 319F(h), the Secretary may conduct and support such activities in accordance with this section and, in consultation with the Director of the National Institutes of Health, as part of the program under section 446, if the activities concern qualified countermeasures. ‘‘(2) QUALIFIED COUNTERMEASURE.—For purposes of this section, the term ‘qualified countermeasure’ means a drug (as that term is defined by section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. -
Can Bioshield Effectively Procure Medical
CAN BIOSHIELD EFFECTIVELY PROCURE MEDICAL COUNTERMEASURES THAT SAFEGUARD THE NATION? HEARING BEFORE THE SUBCOMMITTEE ON EMERGING THREATS, CYBERSECURITY AND SCIENCE AND TECHNOLOGY OF THE COMMITTEE ON HOMELAND SECURITY HOUSE OF REPRESENTATIVES ONE HUNDRED TENTH CONGRESS FIRST SESSION APRIL 18, 2007 Serial No. 110–23 Printed for the use of the Committee on Homeland Security Available via the World Wide Web: http://www.gpoaccess.gov/congress/index.html U.S. GOVERNMENT PRINTING OFFICE 43–559 PDF WASHINGTON : 2009 For sale by the Superintendent of Documents, U.S. Government Printing Office Internet: bookstore.gpo.gov Phone: toll free (866) 512–1800; DC area (202) 512–1800 Fax: (202) 512–2104 Mail: Stop IDCC, Washington, DC 20402–0001 VerDate Nov 24 2008 10:52 Jun 11, 2009 Jkt 000000 PO 00000 Frm 00001 Fmt 5011 Sfmt 5011 H:\DOCS\110-HRGS\110-23\43559.TXT HSEC PsN: DIANE Congress.#13 COMMITTEE ON HOMELAND SECURITY BENNIE G. THOMPSON, Mississippi, Chairman LORETTA SANCHEZ, California, PETER T. KING, New York EDWARD J. MARKEY, Massachusetts LAMAR SMITH, Texas NORMAN D. DICKS, Washington CHRISTOPHER SHAYS, Connecticut JANE HARMAN, California MARK E. SOUDER, Indiana PETER A. DEFAZIO, Oregon TOM DAVIS, Virginia NITA M. LOWEY, New York DANIEL E. LUNGREN, California ELEANOR HOLMES NORTON, District of MIKE ROGERS, Alabama Columbia BOBBY JINDAL, Louisiana ZOE LOFGREN, California DAVID G. REICHERT, Washington SHEILA JACKSON LEE, Texas MICHAEL T. MCCAUL, Texas DONNA M. CHRISTENSEN, U.S. Virgin CHARLES W. DENT, Pennsylvania Islands GINNY BROWN-WAITE, Florida BOB ETHERIDGE, North Carolina MARSHA BLACKBURN, Tennessee JAMES R. LANGEVIN, Rhode Island GUS M. BILIRAKIS, Florida HENRY CUELLAR, Texas DAVID DAVIS, Tennessee CHRISTOPHER P.